Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass: A clinical study

Journal of Thoracic and Cardiovascular Surgery

Volumn 104, Issue 3, 1992, Pages 642-647

  Borowiec, J ^a   Thelin, S ^a   Bagge, L ^a   Nilsson, L ^a   Venge, P ^a   Hansson, H E ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LACTOFERRIN; MYELOPEROXIDASE; OXYGEN RADICAL; PROTAMINE;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME RELEASE; GRANULOCYTE; HUMAN; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL; TISSUE DEGENERATION;

EID: 0026662488     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5223(19)34730-0     Document Type: Article

References (28)

1. Högman CF Bagge L Thoren L The use of blood components in surgical transfusion therapy World J Surg 11 1987 2 13
2. Colman RW Platelet and neutrophil activation in cardiopulmonary bypass Ann Thorac Surg 49 1990 32 34
3. Salama A Hugo F Heinrich D Deposition of terminal C5b-9 complement complexes on erythrocytes and leukocytes during cardiopulmonary bypass N Engl J Med 318 1988 408 414
4. Riegel W Spillner G Schlosser V Hörl WH Plasma levels of main granulocyte components during cardiopulmonary bypass J T horac C ardiovasc S urg 95 1988 1014 1019
5. Larm O Larsson R Olsson P A new non-thrombogenic surface prepared by selective covalent binding of heparin via a modified reducing terminal residue Biomater Med Device Artif Organs 11 1983 161 173
6. Thelin S Bagge L Hultman J Borowiec J Nilsson L Thorelius J Heparin-coated cardiopulmonary bypass circuits reduce blood cell trauma—experiments in the pig Eur J Cardiothorac Surg 5 1991 486 491
7. Bindslev L Eklund J Norlander O Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinised artificial lung Anesthesiology 67 1987 117 120
8. Videm V Nilsson L Venge P Reduced granulocyte activation with heparin coated device in an in vitro model of cardiopulmonary bypass Artif Organs 15 1991 90 95
9. Olofsson T Olsson I Venge P Myeloperoxidase and lactoferrin of blood neutrophils and plasma in chronic granulocytic leukemia Scand J Haematol 18 1977 113 120
10. Hammerschmidt DE Stroncek DF Bowers TK Complement activation and neutropenia occurring during cardiopulmonary bypass J T horac C ardiovasc S urg 81 1981 370 377
11. Fosse E Mollnes TE Ingvaldsen B Complement activation during major operations with or without cardiopulmonary bypass J T horac C ardiovasc S urg 93 1987 860 866
12. Royston D Minty BD Higenbottam TW Wallwork J Jones GJ The effects of surgery with cardiopulmonary bypass on alveolar capillary barrier function in man Ann Thorac Surg 40 1985 139 143
13. Venge P Nilsson L Nyström SO ***Åberg T Serum and plasma measurements of neutrophil granule proteins during cardiopulmonary bypass: a model to estimate human turnover of lactoferrin and myeloperoxidase Eur J Haematol 39 1987 339 345
14. Horl WH Feinstein EI Wanner C Frischmuth N Gosele A Massry SG Plasma levels of main granulocyte components during hemodialysis: comparison of new and reused dialyzers Am J Nephrol 10 1990 53 57
15. Adeyemi EO Campos LB Loizou S Walport MJ Hodgson HJ Plasma lactoferrin and neutrophil elastase in rheumatoid arthritis and systemic lupus erythematosus Br J Rheumatol 29 1990 15 20
16. Carden DL Smith JK Korthuis RJ Neutrophil-mediated microvascular dysfunction in postischemic canine skeletal muscle: role of granulocyte adherence Circ Res 66 1990 1436 1444
17. Peterson VM Ambruso DR Emmett M Bartle EJ Inhibition of colony-stimulating factor (CSF) production by postburn serum: negative feedback inhibition mediated by lactoferrin J Trauma 28 1988 1533 1540
18. Cohen AB MacArthur C Idell S A peptide from alveolar macrophages that releases neutrophil enzymes into the lungs in patients with the adult respiratory distress syndrome Am Rev Respir Dis 137 1988 1151 1158
19. Weiss S Tissue destruction by neutrophils N Engl J Med 320 1989 365 376
20. Cross CE Halliwell B Borish ET Oxygen radicals and human disease Ann Intern Med 107 1987 526 545
21. Anderson BO Brown JM Bensard DD Reversible lung neutrophil accumulation can cause lung injury by elastase-mediated mechanisms Surgery 108 1990 262 267
22. Worthen GS Haslett C Rees AJ Gumbay RS Henson JE Henson PM Neutrophil-mediated pulmonary vascular injury: synergistic effect of trace amounts of lipopolysaccharide and neutrophil stimuli on vascular permeability and neutrophil sequestration in the lung Am Rev Respir Dis 136 1987 19 28
23. Borowiec J Thelin S Bagge L van der Linden J Thörnö E Hansson HE Heparin-coated cardiopulmonary bypass circuits and 25% reduction of heparin dose in coronary artery surgery: a clinical study Upsala J Med Sci 97 1992 55 66
24. Bonser RS Dave JR John L Complement activation before, during and after cardiopulmonary bypass Eur J Cardiothorac Surg 4 1990 291 296
25. Nilsson L Storm KE Thelin S Heparin-coated equipment reduces complement activation during cardiopulmonary bypass in the pig Artif Organs 14 1990 46 48
26. Videm V Svennevig J Fosse E Semb G Österud A Mollnes T Reduced complement activation with heparincoated oxygenator and tubings in coronary bypass operations J T horac C ardiovasc S urg 103 1992 806 813
27. Kirklin JK Chenoweth DE Naftel DC Effects of protamine administration after cardiopulmonary bypass on complement, blood elements and the hemodynamic state Ann Thorac Surg 41 1986 193 199
28. Schapira M Christman BW Neutralization of heparin by protamine Circulation 82 1990 1877 1879